The effect of monamine synthesis inhibitors on the ovarian compensatory hypertrophy.
D000818:Animals; D001835:Body Weight; D001921:Brain / Q000378:metabolism; D002395:Catecholamines / Q000096:biosynthesis; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D005260:Female; D006984:Hypertrophy; D008781:Methyltyrosines / Q000494:pharmacology*; D009929:Organ Size; D010049:Ovarian Diseases / Q000517:prevention & control*; D010053:Ovary / Q000187:drug effects / Q000473:pathology; D010649:Phenylalanine / Q000494:pharmacology; D051381:Rats
D002395:Catecholamines; D008781:Methyltyrosines; D010649:Phenylalanine; D004295:Dihydroxyphenylalanine